Reps. Fortenberry, Craig Joint Statement on Legislation to Cut Insulin Prices: Matt's Act
July 25, 2020
July 25, 2020
WASHINGTON, July 25 -- Rep. Jeff Fortenberry, R-Nebraska, issued the following news release:
Congressman Jeff Fortenberry (NE-01) and Congresswoman Angie Craig (MN-02) offered the following statements on the introduction of Matt's Act, a bill addressing high insulin prices.
"Late last year, a Nebraska dad contacted me about the sky-high cost of his 13-year-old son's insulin. His son Matt, who was newly diagnosed with Type I diabetes, told me that he could not under . . .
Congressman Jeff Fortenberry (NE-01) and Congresswoman Angie Craig (MN-02) offered the following statements on the introduction of Matt's Act, a bill addressing high insulin prices.
"Late last year, a Nebraska dad contacted me about the sky-high cost of his 13-year-old son's insulin. His son Matt, who was newly diagnosed with Type I diabetes, told me that he could not under . . .